Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.
Lung Cancer
What's New
Last Posted: Jun 20, 2024
- 5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1 Expression ≥ 50% Advanced NSCLC.
Vamsidhar Velcheti et al. Clin Lung Cancer 2024 - Prevalence of Potentially Pathogenic Germline Variants Among Adult Patients in the Philippines With Solid Malignancies Who Underwent Tumor Genomic Profiling.
Paula Isabel Franco et al. JCO Glob Oncol 2024 10e2400019 - Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice.
Simon Garinet et al. Pathology 2024 - A deep learning-based radiomics model for predicting lymph node status from lung adenocarcinoma.
Hui Xie et al. BMC Med Imaging 2024 24(1) 121 - Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer.
Jeanna Wallenta Law et al. JCO Precis Oncol 2024 8e2400075 - Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Umberto Malapelle et al. Br J Cancer 2024 - Leveraging Serial Low-Dose CT Scans in Radiomics-based Reinforcement Learning to Improve Early Diagnosis of Lung Cancer at Baseline Screening.
Yifan Wang et al. Radiol Cardiothorac Imaging 2024 6(3) e230196 - The State of State Biomarker Testing Insurance Coverage Laws
- Trial of Electronic Medical Record Integrated Next-Generation Sequencing Ordering in Veterans Affairs Cancer Care.
James H Stoeckle et al. JCO Precis Oncol 2024 8e2300463 - VLST: Virtual Lung Screening Trial for Lung Cancer Detection Using Virtual Imaging Trial.
Fakrul Islam Tushar et al. ArXiv 2024 - Application of machine learning for lung cancer survival prognostication-A systematic review and meta-analysis.
Alexander J Didier et al. Front Artif Intell 2024 71365777 - Application value of the automated machine learning model based on modified CT index combined with serological indices in the early prediction of lung cancer.
Leyuan Meng et al. Front Public Health 2024 121368217 - Predicting the risk of lung cancer using machine learning: A large study based on UK Biobank.
Siqi Zhang et al. Medicine (Baltimore) 2024 103(16) e37879 - Targeted next-generation sequencing of 491 lung cancers in clinical practice: Implications for future detection strategy and targeted therapy.
Xiao-Dan Liu et al. Heliyon 2024 10(6) e27591 - Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study.
Yu Zhang et al. PeerJ 2024 12e17098 - Telemedicine-Enhanced Lung Cancer Screening Using Mobile Computed Tomography Unit with Remote Artificial Intelligence Assistance in Underserved Communities: Initial Results of a Population Cohort Study in Western China.
Wenjuan Tao et al. Telemed J E Health 2024 - Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
Philip C Mack et al. Oncologist 2024 - Potential of radiomics analysis and machine learning for predicting brain metastasis in newly diagnosed lung cancer patients.
S Yichu et al. Clin Radiol 2024 - NSCLC Digital PCR Panel Returns Low-Input Sample Results Where Sequencing Fails.
Leah Rowland Herdt et al. Diagnostics (Basel) 2024 14(3) - Exploring pollutant joint effects in disease through interpretable machine learning.
Shuo Wang et al. J Hazard Mater 2024 467133707 - Genomic Landscape of NSCLC in the Republic of Ireland.
Rachel J Keogh et al. JTO Clin Res Rep 2024 5(2) 100627 - Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review.
Clare Meernik et al. J Natl Cancer Inst 2024 2 - Real-World Effectiveness of Lung Cancer Screening Using Deep Learning-Based Counterfactual Prediction.
Zheng Feng et al. Stud Health Technol Inform 2024 310419-423 - Concurrent Circulating Tumor DNA and Tissue Genotyping-Ready for Prime Time?
Benjamin A Bleiberg et al. JAMA Netw Open 2024 1 (1) e2351679 - Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort.
Wade T Iams et al. JAMA Netw Open 2024 7(1) e2351700 - Editorial: World lung cancer awareness month 2022: artificial intelligence for clinical management of lung cancer.
Parul Agarwal et al. Front Oncol 2024 131351016 - Predicting Phase 1 Lymphoma Clinical Trial Durations Using Machine Learning: An In-Depth Analysis and Broad Application Insights.
Bowen Long et al. Clin Pract 2024 14(1) 69-88 - Benefits of Implementing Reflex Genomic Analysis for Nonsmall Cell Lung Cancer.
Benjamin F Smith et al. J Appl Lab Med 2024 9(1) 28-40 - Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan.
Hsin-Yi Wang et al. JCO Precis Oncol 2024 8e2300314 - Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study.
D-W Kang et al. ESMO Open 2024 9(1) 102200 - Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.
Zakile A Mfumbilwa et al. Pharmacoeconomics 2024 - Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches.
Matthew T Warkentin et al. Thorax 2024 - Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla platform: a real-world two-center experience in Greece.
Kleita Michaelidou et al. Expert Rev Mol Diagn 2024 1-10 - Lung cancer in patients who have never smoked - an emerging disease.
Jaclyn LoPiccolo et al. Nat Rev Clin Oncol 2024 1 - Genomic landscape and actionable mutations of brain metastases derived from non-small cell lung cancer: A systematic review.
Lily J Andrews et al. Neurooncol Adv 2023 5(1) vdad145 - Sotorasib versus Docetaxel for treatment of US and Chinese patients with advanced non-small-cell lung cancer with KRAS p.G12C-mutated: A cost-effectiveness analysis to inform drug pricing.
Yunlin Jiang et al. Medicine (Baltimore) 2023 102(50) e36387 - Air quality and cancer risk in the All of Us Research Program.
Andrew Craver et al. Cancer Causes Control 2023 - Cost-Effectiveness of Comprehensive Genomic Profiling in Patients With Non-Small Cell Lung Cancer for the Colombian Health System.
Oscar Gamboa et al. Value Health Reg Issues 2023 39115-125 - Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis.
Anika Kästner et al. Lancet Reg Health Eur 2023 36100788 - The Prognosis of Advanced Non-Small Cell Lung Cancer Patients with Precision-Targeted Therapy Guided by NGS Testing or Routine Testing.
Tingting Tu et al. Cancer Manag Res 2023 151307-1318 - Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer.
Caiyue Ren et al. Eur J Med Res 2023 28(1) 554 - Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis.
Cheng Chen et al. medRxiv 2023 - Rate of Pathogenic Germline Variants in Patients With Lung Cancer.
Steven Sorscher et al. JCO Precis Oncol 2023 7e2300190 - Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
John V Heymach et al. N Engl J Med 2023 10 (18) 1672-1684 - Deep learning for the detection of benign and malignant pulmonary nodules in non-screening chest CT scans.
Ward Hendrix et al. Commun Med (Lond) 2023 3(1) 156 - Machine Learning Techniques to Predict Timeliness of Care among Lung Cancer Patients.
Arul Earnest et al. Healthcare (Basel) 2023 11(20) - Diagnosis and Treatment of Advanced ALK Rearrangement-Positive Non-Small-Cell Lung Cancer in Portugal: Results of a National Questionnaire.
Ana Figueiredo et al. Drugs Real World Outcomes 2023 - The health inequality impact of liquid biopsy to inform first-line treatment of advanced non-small cell lung cancer - a distributional cost-effectiveness analysis.
Jeroen P Jansen et al. Value Health 2023 - Emerging cancer risks in BRCA2 pathogenic germline variant carriers.
Patrick R Benusiglio et al. Eur J Hum Genet 2023 9 - Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).
Karen Leroy et al. PLoS One 2023 18(9) e0291495 - Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer.
Udit Nindra et al. Intern Med J 2023 - Biomarker Testing, Treatment, and Outcomes in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Using a Real-World Database.
Naleen Raj Bhandari et al. J Natl Compr Canc Netw 2023 21(9) 934-944.e1 - Clinical importance of the range of detectable variants between the Oncomine Dx target test and a conventional single-gene test for EGFR mutation.
Tadashi Sakaguchi et al. Sci Rep 2023 13(1) 13759 - A Machine Learning-Based Model to Predict In-Hospital Mortality of Lung Cancer Patients: A Population-Based Study of 523,959 Cases.
Que N N Tran et al. Adv Respir Med 2023 91(4) 310-323 - Machine learning strengthened prediction of tracheal, bronchus, and lung cancer deaths due to air pollution.
Jagadish Kumar Mogaraju et al. Environ Sci Pollut Res Int 2023 - Predicting lung cancer survival based on clinical data using machine learning: A review.
Fatimah Abdulazim Altuhaifa et al. Comput Biol Med 2023 165107338 - Germline EGFR mutations and familial lung cancer.
Geoffrey R Oxnard et al. J Clin Oncol 2023 101200JCO2301372 - T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study).
Chih-Hsi Scott Kuo et al. Am J Cancer Res 2023 13(7) 3100-3112 - Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations.
Matthew R Trendowski et al. Cancer Epidemiol Biomarkers Prev 2023 8 - Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data.
Jeffrey A Scott et al. JCO Oncol Pract 2023 OP2200611
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: